COMPOSITION
Each film-coated tablet contains:
Dienogest IP …………… 2mg
Excipients ………………. q.s
DESCRIPTION
Dinobliss is utilized in the treatment of pelvic pain associated with endometriosis. It’s a progestin, which is similar to the female hormone, and that works by suppressing the production of estrogen hormone causing endometrium.
PHARMACOLOGY
Dinobliss reduces the endogenous production of estrogen and thereby suppresses the trophic effects of estrogen on both the eutopic and ectopic endometrium. When given continuously, dienogest leads to a hyperprogestogenic and moderately hypoestrogenic endocrine environment causing initial decidualization of endometrial tissue. Additional direct antiproliferative, immunologic, and antiangiogenic effects seem to contribute to the inhibitory action of Dinobliss on cell proliferation and to the reduction of pelvic pain associated with endometriosis. Dinobliss is a novel nortestosterone derivative with no androgenic but rather an antiandrogenic activity. Despite its low affinity to the progesterone receptor, Dinobliss has a strong progestogenic effect with no significant androgenic, mineralocorticoid, or glucocorticoid activity.